New York, Feb. 08, 2023 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Pharmaceutical API Manufacturing Global Market Report 2023" - https ...

Industry urges govt to tap idle API manufacturing capacity to avoid costly duplication: Shardul Nautiyal, Mumbai Monday, June 22, 2026, 08:00 Hrs [IST] Industry associations have ...

The global biotech API manufacturing services market, valued at US$ 38.9 Billion in 2022, is projected to grow at a CAGR of 7.1% from 2023 to 2031, surpassing US$ 73 Billion by 2031. biotech API ...

Hyderabad-based HRV Pharma is attempting to redefine the traditional pharmaceutical business model by building an active pharmaceutical ingredient (API) company without owning any manufacturing ...

Therapiva, a joint venture of Abu Dhabi-based Neopharma and India’s Laxai Life Sciences, says it has a GMP manufacturing plant in India. It will now add Dr. Reddy's entire API manufacturing business. ...

Efficiency and adaptability are crucial in the ever-evolving manufacturing industry. As manufacturers adopt advanced technologies like IoT, AI, and cloud computing, the need for seamless integration ...

Manufacturers in Europe and the United States have announced plans for new in-country API development and manufacturing capabilities. Manufacturers in Europe and the United States have announced plans ...

(MENAFN- IMARC Group) An API (Active Pharmaceutical Ingredient) is the biologically active component of a drug that produces the intended therapeutic effect. It is the essential substance in medicines ...

After decades of dependence on imported Active Pharmaceutical Ingredients (APIs) and multilateral aid, Africa faces a critical turning point, seeking to assert control over its health and economic ...